Waldencast Acquisition Corp.

Status: Deal Closed
U=S+W/3 W=S@11.5
IPO Proceeds, $M $345.00M
IPO Date Mar 16, 2021
CEO Michel Brousset
Left Lead Credit Suisse
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Consumer

Health, Beauty, and Wellness industries

IPO Geography Global
Target Company Waldencast
Deal Announced Nov 15, 2021
Deal Size, $M $1,240.00M
Deal Sector Consumer
Deal Geography Global
SEC Filings www.sec.gov
Approval Vote Jul 25, 2022
Amendment Vote TBD
Closing Date Jul 27, 2022
Formerly WALD WALD WALDW

Sign up for Free Trial

No credit card required

Sign in for more on Waldencast Acquisition Corp.:

  • Structure and cap table
  • 10 directors & officers
  • 34 filings and events
  • 2 underwriters
  • 4 deal advisors
  • 3 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Michel Brousset 48 Chief Executive Officer and Director
Felipe Dutra 55 Executive Chairman of the Board of Directors
Michel Brousset Principal Financial Officer
Hind Sebti 42 Chief Operating Officer and Chief Growth Officer
Cristiano Souza 46 Director
Sarah Brown 57 Director
Juliette Hickman 46 Director
Lindsay Pattison 47 Director
Zack Werner 32 Director
Aaron Chatterley 55 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Credit Suisse Joint BR 16,500,000 units
JP Morgan Joint BR 13,500,000
30,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee
3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings
Feb 22, 2021 Initial S-1
Mar 1, 2021

Sign In to view filing content.

Mar 11, 2021

Sign In to view filing content.

Mar 16, 2021

Sign In to view filing content.

Mar 17, 2021 424B4 IPO Prospectus
Mar 18, 2021

Sign In to view filing content.

May 7, 2021

Sign In to view filing content.

Aug 17, 2021

Sign In to view filing content.

Nov 15, 2021

Sign In to view filing content.

Nov 17, 2021

Sign In to view filing content.

Dec 22, 2021

Sign In to view filing content.

Feb 14, 2022

Sign In to view filing content.

Mar 7, 2022 F-4/A Amendment #1 to registration statement containing preliminary proxy for Obagi and Milk Makeup business combination
Mar 21, 2022

Sign In to view filing content.

Apr 22, 2022

Sign In to view filing content.

Apr 26, 2022

Sign In to view filing content.

Apr 27, 2022

Sign In to view filing content.

Apr 27, 2022

Sign In to view filing content.

May 13, 2022

Sign In to view filing content.

Jun 15, 2022

Sign In to view filing content.

Jun 16, 2022

Sign In to view filing content.

Jun 27, 2022

Sign In to view filing content.

Jun 30, 2022

Sign In to view filing content.

Jul 1, 2022

Sign In to view filing content.

Jul 5, 2022

Sign In to view filing content.

Jul 7, 2022

Sign In to view filing content.

Jul 15, 2022

Sign In to view filing content.

Jul 25, 2022

Sign In to view filing content.

Jul 26, 2022

Sign In to view filing content.

Jul 27, 2022

Sign In to view filing content.

Aug 3, 2022

Sign In to view filing content.

Aug 24, 2022

Sign In to view filing content.

Sep 27, 2022

Sign In to view filing content.

Oct 13, 2022

Sign In to view filing content.

Shareholders

Sign in to view shareholders 13F filing data.